Process for controlling crystal structure of risedronate
Details for Australian Patent Application No. 2004261561 (hide)
International Classifications
Event Publications
16 February 2006 PCT application entered the National Phase
PCT publication WO2005/012314 Priority application(s): WO2005/012314
26 June 2008 Application Accepted
Published as AU-B-2004261561
23 October 2008 Standard Patent Sealed
18 February 2010 Assignment Registered
The Procter & Gamble Company The patent has been assigned to Warner Chilcott Company, LLC
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004261567-Process for the preparation of cPLA2 inhibitors
2004261560-Metal containers having an easily openable end and method of manufacturing the same
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser